biomarkers, tumor

Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy
Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Suzana Matković, Dušica Gavrilović, Aleksandra Ninković, Vladimir Jurišić, Nada Babović

Journal of Clinical Pathology May 2024, 77 (5) 343-351; DOI: 10.1136/jcp-2022-208615
Comparison of assessment of programmed death-ligand 1 (PD-L1) status in triple-negative breast cancer biopsies and surgical specimens
Aurelia Noske, Katja Steiger, Simone Ballke, Marion Kiechle, Dirk Oettler, Wilfried Roth, Wilko Weichert

Journal of Clinical Pathology Apr 2024, 77 (4) 239-245; DOI: 10.1136/jcp-2022-208637
Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory
Réiltín Werner, Amy Connolly, Michael Bennett, Collette K Hand, Louise Burke

Journal of Clinical Pathology Apr 2024, 77 (4) 278-283; DOI: 10.1136/jcp-2022-208625
Kinase expression in angiomatoid fibrous histiocytoma: panTRK is commonly expressed in the absence of NTRK rearrangement
Ana Cristina Vargas, Christopher Joy, Fiona M Maclean, Fiona Bonar, Daniel D Wong, Anthony J Gill, Alison L Cheah

Journal of Clinical Pathology Apr 2024, 77 (4) 251-254; DOI: 10.1136/jcp-2023-209225
Increased PI3K pathway activity is associated with recurrent breast cancer in patients with low and intermediate 21-gene recurrence score
Lawrence Hsu Lin, Yvonne Wesseling-Rozendaal, Varshini Vasudevaraja, Guomiao Shen, Margaret Black, Dianne van Strijp, Sigi Neerken, Paul A van de Wiel, George Jour, Paolo Cotzia, Farbod Darvishian, Matija Snuderl

Journal of Clinical Pathology Feb 2024, jcp-2023-209344; DOI: 10.1136/jcp-2023-209344
Genomic discordances and heterogeneous mutational burden, PD-L1 expression and immune infiltrates of non-small cell lung cancer metastasis
Jianghua Wu, Luning Mao, Wanjun Lei, Wei Sun, Xin Yang, Yanhui Zhang, Xiaozheng Huang, Dongmei Lin

Journal of Clinical Pathology Feb 2024, jcp-2023-209328; DOI: 10.1136/jcp-2023-209328
Screening for and diagnosis of monoclonal gammopathy
Yuh Ping Chong, Say Min Lim, Tze Ping Loh, Peter Mollee, Nilika Wijeratne, Kay Weng Choy

Journal of Clinical Pathology Nov 2023, 76 (11) 727-733; DOI: 10.1136/jcp-2023-208774
Performance evaluation and clinical impact of the Oncomine Myeloid Research Assay for gene expression analysis in myeloid haematologic malignancies
Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Chul Won Choi, Ha Nui Kim, Jeong Ah Kwon, Soo-Young Yoon, Jung Yoon

Journal of Clinical Pathology Nov 2023, 76 (11) 778-783; DOI: 10.1136/jcp-2022-208425
Prognostic value and tumour microenvironment characteristics of the Glasgow Microenvironment Score in primary triple-negative breast cancer
Xunxi Lu, Yue Wang, Mengting He, Zongchao Gou

Journal of Clinical Pathology Feb 2024, 77 (2) 128-134; DOI: 10.1136/jcp-2022-208601
Machine-learning-based image analysis algorithms improve interpathologist concordance when scoring PD-L1 expression in non-small-cell lung cancer
Alexander Haragan, Piya Parashar, Danielle Bury, Gregory Cross, John R Gosney

Journal of Clinical Pathology Feb 2024, 77 (2) 140-144; DOI: 10.1136/jcp-2023-208978

Main menu

biomarkers, tumor

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

biomarkers, tumor

Pages